Market Tracker

04/20 6:02pm ET

Repligen Corp (NASDAQ:RGEN)

33.18
Delayed Data
As of Apr 20
 +1.09 / +3.40%
Today’s Change
14.92
Today|||52-Week Range
34.15
+67.58%
Year-to-Date

Today’s Trading

Previous close32.09
Today’s open32.20
Day’s range31.77 - 33.28
Volume363,942
Average volume (3 months)379,088
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 04/20/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+17.33%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio135.1
Price/Sales10.13
Price/Book9.41

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...-1.34-4.97%
ARRYArray Biopharma Inc+0.13+1.78%
ZSPHZS Pharma Inc-0.63-1.55%
PRTAProthena Corporation...-0.21-0.58%
Data as of 4:00pm ET, 04/20/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$0.07
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer &
Director
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts